Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Madagascar
Madagascar: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.6% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Madagascar, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Madagascar is 0.6%, measured in 2024.
Compared with earlier readings it is up 20.0% on the previous year and down 14.3% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Madagascar peaked at 0.7% in 2015 and was at its lowest, 0.5%, in 2020.
That places Madagascar 60th out of 247 countries with data for 2024, putting it in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Madagascar, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.7% | — |
| 2016 | 0.7% | +0.0% |
| 2017 | 0.6% | -14.3% |
| 2018 | 0.6% | +0.0% |
| 2019 | 0.6% | +0.0% |
| 2020 | 0.5% | -16.7% |
| 2021 | 0.5% | +0.0% |
| 2022 | 0.5% | +0.0% |
| 2023 | 0.5% | +0.0% |
| 2024 | 0.6% | +20.0% |
Madagascar compared with similar countries
- Madagascar's 0.6% is below the median for low income countries, which is 0.7%, 86% of the median. (23 countries reporting)
- Madagascar's 0.6% is below the median for Sub-Saharan Africa, which is 1.1%, 55% of the median. (45 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.7% | 5 |
| 2020s | 0.5% | 0.5% | 0.6% | 5 |
Countries ranked near Madagascar
- 60 Côte d'Ivoire 0.6% compare
- 60 Ethiopia 0.6% compare
- 60 Lao People's Democratic Republic 0.6% compare
- 60 Micronesia (Federated States of) 0.6% compare
- 60 Nauru 0.6% compare
- 60 Northern Mariana Islands 0.6% compare
- 60 Palau 0.6% compare
- 60 Tonga 0.6% compare
- 60 Cote d'Ivoire 0.6% compare
- 60 Laos 0.6% compare
- 60 Naoero 0.6% compare
More development goals data for Madagascar
- Red List Index 0.724 (2025)
- Number of refugees per 100,000 population, by country of origin 1.83 (2025)
- Manufacturing value added per capita 52.05 (2025)
- Number of transboundary breeds 17 (2025)
- Number of transboundary breeds (not extinct) 17 (2025)
- Number of transboundary breeds with unknown risk status 17 (2025)
- Number of local breeds with unknown risk status 17 (2025)
- Number of local breeds (not extinct) 17 (2025)
- Number of local breeds kept in the country 17 (2025)
- Infant deaths 42,981 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Madagascar?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Madagascar was 0.6% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Madagascar?
- The highest recorded value was 0.7% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Madagascar?
- The lowest recorded value was 0.5% in 2020.
- How does Madagascar rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Madagascar ranks 60th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Madagascar?
- Over the last ten years it is down 14.3%. The long-run trend across the full record is falling.
- Where does this Madagascar data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).